Allergy Treatment Market Trend, Share, Growth, Size and Forecast 2032
Allergy Treatment Market By Allergy Type (rhinitis, eye allergy, skin allergy, asthma, and another allergy.), By Treatment Type (antihistamines, anti-allergy medicine, decongestants, corticosteroids, calcineurin, leukotriene, anti-IgE, cromoglicate, immunotherapy, and mast cell stabilizers.), By End User (clinics, hospital, home use, medical store, and others.) And By Region: - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032
| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 1216.79 Million | USD 1986.96 Million | 5.6% | 2023 |
Description
What is the Allergy Treatment Market Size?
According to the report published by Zion Market Research, the global Allergy Treatment Market size was valued at USD 1216.79 Million in 2023 and is predicted to reach USD 1986.96 Million by the end of 2032. The market is expected to grow with a CAGR of 5.6% during the forecast period. The report analyzes the global Allergy Treatment Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Allergy Treatment industry.
Global Allergy Treatment Market: Overview
An allergy is an immune system’s sharp sensitivity. An allergy happens when a foreign material that is risk-free in nature has a reaction to the immune system. These foreign materials are dubbed as allergens. Some of the allergens that impact the immune system are dust mite, pollens, animal dander, mold, and cockroach. Animal dander, dust mite, and mold can be the reason for indoor allergy issues. Allergy can be of different kinds such as Rhinitis, eye allergy, skin allergy, and asthma. As per the World Allergy Organization, almost 30–40% of the population in the world was impacted in 2011 by the allergic condition. Stern allergy can be life to intimidate for some users as allergy harshness lowers the operations of organs, for instance, allergic asthma causes the poor functioning of lungs.
Global Allergy Treatment Market: Growth Factors
All over the world, altering lifestyle, rising population of the patient with different kinds of allergies, and increasing environmental pollution boost the global allergy treatment market. Rising number of users with different allergies such as eye allergy, skin allergy, asthma, and Rhinitis, increasing demand for enhanced therapy for allergy treatment, changes in dietary habits, government programs, and rising activities of research and development are some of the reason that power the development of the global allergy treatment market. On the other hand, side effects from immunotherapy and high price of immunotherapy for allergy treatment act as a negative factor hindering the global allergy treatment market.
Key Insights
- As per the analysis shared by our research analyst, the global Allergy Treatment Market is estimated to grow annually at a CAGR of around 5.6% over the forecast period (2024-2032).
- In terms of revenue, the global Allergy Treatment Market size was valued at around USD 1216.79 Million in 2023 and is projected to reach USD 54.03 Billion by 2032.
- Based on the type of allergy, allergic rhinitis stands out as the most dominant segment by type of allergy. This condition, characterized by nasal inflammation due to allergens like pollen or dust, affects a significant portion of the population worldwide. Its high prevalence, combined with the chronic nature of the symptoms, drives a substantial demand for treatments, making it a leading segment in the allergy treatment market.
- Based on the end user, hospital pharmacies emerge as the dominant segment. These pharmacies play a crucial role in the distribution and dispensation of allergy treatments, especially for severe allergic reactions that require immediate medical attention. The centralized nature of hospital pharmacies ensures efficient management and availability of essential medications, contributing to their leading position in the market.
- Based on the treatment type, anti-allergy drugs hold the largest market share. These medications, including antihistamines, decongestants, and corticosteroids, are widely used due to their effectiveness in providing rapid relief from allergy symptoms. Their ease of administration and immediate symptomatic relief make them the preferred choice for both patients and healthcare providers.
- Based on the region, North America dominates the allergy treatment market. This can be attributed to the region's advanced healthcare infrastructure, high awareness levels about allergic conditions, and significant investments in research and development of new treatments. The combination of these factors ensures that North America remains at the forefront of the allergy treatment industry.
Recent Developments:
- In May 2025, Sanofi received FDA approval to expand the indication for Dupixent (dupilumab) to include pediatric patients aged 6 months to 5 years with moderate-to-severe atopic dermatitis, further strengthening its pediatric allergy treatment portfolio.
- In April 2025, Regeneron and Sanofi announced positive Phase III results for their anti-IL-33 monoclonal antibody, demonstrating notable efficacy in reducing symptoms of seasonal allergic rhinitis.
- In March 2025, Nestlé Health Science launched a new peanut oral immunotherapy (OIT) product in Europe, marking a significant advancement in standardized food allergy desensitization therapies.
Allergy Treatment Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | Allergy Treatment Market |
| Market Size in 2023 | USD 1216.79 Million |
| Market Forecast in 2032 | USD 1986.96 Million |
| Growth Rate | CAGR of 5.6% |
| Number of Pages | 192 |
| Key Companies Covered | Allergopharma, Allergy Therapeutics, Alerpharma S.A, Allergon AB, Genentech Inc., Allergan, Inc., McNeil Consumer Healthcare, Schering-Plough Corporation, Meda Pharmaceuticals, Inc, Collegium Pharmaceutical, Inc., Vicks, and Sepracor, Inc |
| Segments Covered | By type of allergy, By end user, By treatment type and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Global Allergy Treatment Market: Segmentation
Based on the allergy type, the global allergy treatment market is classified into rhinitis, eye allergy, skin allergy, asthma, and another allergy. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.
On the basis of allergy treatment type, the global allergy treatment market is divided antihistamines, anti-allergy medicine, decongestants, corticosteroids, calcineurin, leukotriene, anti-IgE, cromoglicate, immunotherapy, and mast cell stabilizers.
Based on the end user, the global allergy treatment market is classified into clinics, hospital, home use, medical store, and others.
The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Global Allergy Treatment Market: Regional Analysis
The global allergy treatment market is divided into 7 key regions based on geographic areas: South America, North America, Western Europe, Eastern Europe, Japan, Asia Pacific, and Middle East & Africa. North America is chased by Europe and rules the global allergy treatment market owing to rising number of users with different kinds of allergies comprising skin allergy, respiratory allergy, and eye allergy, developed infrastructure for healthcare, growing environmental pollution, and rising requirement for immunotherapy for the cure of allergies in this area.
Asia-Pacific is the quickest rising area for global allergy treatment market owing to increasing patient population for allergy, developing infrastructure for healthcare, rising consciousness related to enhanced immunotherapy for the treatment of allergies obtainable in the market, and increasing spending of government in the healthcare sector in this area.
Global Allergy Treatment Market: Competitive Players
Some of the major market companies in global allergy treatment market are
- Allergopharma
- Allergy Therapeutics
- Alerpharma S.A
- Allergon AB
- Genentech Inc.
- Allergan, Inc.
- McNeil Consumer Healthcare
- Schering-Plough Corporation
- Meda Pharmaceuticals, Inc
- Collegium Pharmaceutical, Inc.
- Vicks
- Sepracor, Inc.
The Global Allergy Treatment Market segments are as follows:
By Allergy Type
- Rhinitis
- Eye Allergy
- Skin Allergy
- Asthma
- Another Allergy
By Treatment Type
- Antihistamines
- Anti-allergy Medicine
- Decongestants
- Corticosteroids
- Calcineurin
- Leukotriene
- Anti-ige
- Cromoglicate
- Immunotherapy
- Mast Cell Stabilizers
By End User
- Clinics
- Hospital
- Home Use
- Medical Store
- Others
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- What Reports Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
Table Of Content
FrequentlyAsked Questions
Allergy treatment includes medicines and therapies used to reduce allergic reactions. It helps control symptoms caused by allergens such as pollen, food, or dust.
The global Allergy Treatment market is expected to be driven by the Driven by rising incidence of allergies, increasing pollution levels, and growing awareness of allergy management. Development of advanced biologics and immunotherapies supports market growth.
According to study, the global Allergy Treatment market size was worth around USD 1216.79 Million in 2023 and is predicted to grow to around USD 1986.96 Million By 2032.
The global Allergy Treatment market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.6% during the forecast period from 2024-2032.
The global Allergy Treatment industry is projected to be challenged by Challenges include long treatment durations reducing adherence, high costs for biologics, and variability in diagnosis and allergen exposure across populations.
Which application areas will offer significant growth opportunities in the Allergy Treatment market?
The Opportunities include rising allergy prevalence, growth of immunotherapy and biologic treatments, and development of personalized and at-home allergy management solutions will offer significant growth opportunities in the Allergy Treatment market.
Biologic therapies targeting specific immune pathways; improved immunotherapy (SLIT/patch) formats; at-home monitoring and personalized treatment plans are the emerging trends and innovations impacting the Allergy Treatment market.
The global Allergy Treatment market is expected to be led by North America during the forecast period.
Some of the prominent players operating in the global Allergy Treatment market are; Allergopharma, Allergy Therapeutics, Alerpharma S.A, Allergon AB, Genentech Inc., Allergan, Inc., McNeil Consumer Healthcare, Schering-Plough Corporation, Meda Pharmaceuticals, Inc, Collegium Pharmaceutical, Inc., Vicks, and Sepracor, Inc and others.
The report explores crucial aspects of the Allergy Treatment market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
